Aurobindo Pharma to launch oncology, respiratory products in US by 2021 Industry-Economic Times — November 18, 2018 comments off The company is also focussing on securing intellectual property (IP) and ramping up and filing of specialty products.
The company is also focussing on securing intellectual property (IP) and ramping up and filing of specialty products.